OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Eikonizo Therapeutics, Inc.

1 Projects | 1 Researchers | $1,001,051 Invested

2017

Eikonizo Therapeutics, Inc.

Janice Kranz, PhD

De-risking the therapeutic opportunity of HDAC6 for neurodegenerative tauopathies

  • Funding Amount: $1,001,051
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Tau
  • Status: Closed